Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ballard, C.
1998.
Commentary.
Advances in Psychiatric Treatment,
Vol. 4,
Issue. 6,
p.
366.
Gormley, Niall
and
Rizwan, Mohammed R.
1998.
Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.
International Journal of Geriatric Psychiatry,
Vol. 13,
Issue. 6,
p.
410.
Ballard, C.
Morris, C.
and
Piggott, M.
1999.
Dementias.
p.
137.
Ballard, Clive
Holmes, Clive
McKeith, Ian
Neill, David
O’Brien, John
Cairns, Nigel
Lantos, Peter
Perry, Elaine
Ince, Paul
and
Perry, Robert
1999.
Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer’s Disease.
American Journal of Psychiatry,
Vol. 156,
Issue. 7,
p.
1039.
Ballard, Clive
and
Walker, Matthew
1999.
Neuropsychiatric aspects of alzheimer’s disease.
Current Psychiatry Reports,
Vol. 1,
Issue. 1,
p.
49.
Rojas‐Fernandez, Carlos H.
Lanctôt, Krista L.
Allen, David D.
and
MacKnight, Chris
2001.
Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: Time for a Different Paradigm?.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 21,
Issue. 1,
p.
74.
Court, J.A
Ballard, C.G
Piggott, M.A
Johnson, M
O'Brien, J.T
Holmes, C
Cairns, N
Lantos, P
Perry, R.H
Jaros, E
and
Perry, E.K
2001.
Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies.
Pharmacology Biochemistry and Behavior,
Vol. 70,
Issue. 4,
p.
571.
Eustace, A.
Coen, R.
Walsh, C.
Cunningham, C. J.
Walsh, J. B.
Coakley, D.
and
Lawlor, B. A.
2002.
A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
International Journal of Geriatric Psychiatry,
Vol. 17,
Issue. 10,
p.
968.
Wancata, Johannes
Windhaber, Johann
Krautgartner, Monika
and
Alexandrowicz, Rainer
2003.
The Consequences of Non-Cognitive Symptoms of Dementia in Medical Hospital Departments.
The International Journal of Psychiatry in Medicine,
Vol. 33,
Issue. 3,
p.
257.
2003.
Drugs for disruptive features in dementia.
Drug and Therapeutics Bulletin,
Vol. 41,
Issue. 1,
p.
1.
Fischer, Corinne
Bozanovic-Sosic, Radenka
and
Norris, Mireille
2004.
Review of delusions in dementia.
American Journal of Alzheimer's Disease & Other Dementias®,
Vol. 19,
Issue. 1,
p.
19.
De Deyn, Peter Paul
Carrasco, Manuel Martín
Deberdt, Walter
Jeandel, Claude
Hay, Donald P.
Feldman, Peter D.
Young, Carrie A.
Lehman, Deborah L.
and
Breier, Alan
2004.
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
International Journal of Geriatric Psychiatry,
Vol. 19,
Issue. 2,
p.
115.
Alberca, R.
and
Montes, E.
2004.
Brain Damage and Repair.
p.
563.
Fischer, C.
Ladowsky-Brooks, R.
Millikin, C.
Norris, M.
Hansen, K.
and
Rourke, S. B.
2006.
Neuropsychological functioning and delusions in dementia:A pilot study.
Aging & Mental Health,
Vol. 10,
Issue. 1,
p.
27.
Ballard, Clive
and
Howard, Robert
2006.
Neuroleptic drugs in dementia: benefits and harm.
Nature Reviews Neuroscience,
Vol. 7,
Issue. 6,
p.
492.
Meagher, David
and
Trzepacz, Paula T.
2007.
Phenomenological Distinctions Needed in DSM-V: Delirium, Subsyndromal Delirium, and Dementias.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 19,
Issue. 4,
p.
468.
Ballard, Clive
Corbett, Anne
Chitramohan, Ramilgan
and
Aarsland, Das
2009.
Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions.
Current Opinion in Psychiatry,
Vol. 22,
Issue. 6,
p.
532.
Seitz, Dallas P
Adunuri, Nikesh
Gill, Sudeep
Gruneir, Andrea
Herrmann, Nathan
Rochon, Paula
and
Seitz, Dallas P
2010.
Cochrane Database of Systematic Reviews.
Seitz, Dallas P
Adunuri, Nikesh
Gill, Sudeep S.
Gruneir, Andrea
Herrmann, Nathan
and
Rochon, Paula
2011.
Antidepressants for agitation and psychosis in dementia.
Cochrane Database of Systematic Reviews,
Ballard, Clive
and
Corbett, Anne
2012.
Advances in Alzheimer’s Disease Management.
p.
68.